Form 4 for BMY Bristol Myers Squibb
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-16 · accession 0000014272-21-000234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-17 | 2021-12-16 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale | $61.99 | -19.3K | 32.0K | -38% | -$1.20M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2021-12-16 | S | D | 6,198 | $61.99 | 45,060 | D | — | — | |
| 2 | Common | Common Stock, $0.10 par value | 2021-12-16 | S | D | 13,100 | $61.99 | 31,960 | D | — | — |